Dawn Livingstone
Western General Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Dawn Livingstone.
Endocrinology | 2000
Dawn Livingstone; Gregory C. Jones; Kenneth Smith; Pauline Jamieson; Ruth Andrew; Christopher J. Kenyon; Brian R. Walker
The role of glucocorticoids in obesity is poorly understood. Observations in obese men suggest enhanced inactivation of cortisol by 5alpha-reductase and altered reactivation of cortisone to cortisol by 11betahydroxysteroid dehydrogenase type 1 (11betaHSD1). These changes in glucocorticoid metabolism may influence corticosteroid receptor activation and feedback regulation of the hypothalamic-pituitary-adrenal axis (HPA). We have compared corticosterone metabolism in vivo and in vitro in male obese and lean Zucker rats, aged 9 weeks (n = 8/group). Steroids were measured in 72-h urine and 0900 h trunk blood samples. 5alpha-Reductase type 1 and 11betaHSD activities were assessed in dissected tissues. Obese animals were hypercorticosteronemic and excreted more total corticosterone metabolites (2264+/-623 vs. 388+/-144 ng/72 h; P = 0.003), with a greater proportion being 5alpha-reduced or 11-oxidized. 11-Dehydrocorticosterone was also elevated in plasma (73+/-9 vs. 18+/-2 nM; P = 0.001) and urine (408+/-111 vs. <28 ng/72 h; P = 0.01). In liver of obese rats, 5alpha-reductase type 1 activity was greater (20.6+/-2.7% vs. 14.1+/-1.5%; P<0.04), but 11betaHSD1 activity (maximum velocity, 3.43+/-0.56 vs. 6.57+/-1.13 nmol/min/mg protein; P = 0.01) and messenger RNA levels (0.56+/-0.08 vs. 1.03+/-0.15; P = 0.02) were lower. In contrast, in obese rats, 11betaHSD1 activity was not different in skeletal muscle and sc fat and was higher in omental fat(36.4+/-6.2 vs. 19.2+/-6.6; P = 0.01), whereas 11betaHSD2 activity was higher in kidney (16.7+/-0.6% vs. 11.3+/-1.5%; p = 0.01). We conclude that greater inactivation of glucocorticoids by 5alpha-reductase in liver and 11betaHSD2 in kidney combined with impaired reactivation of glucocorticoids by 11betaHSD1 in liver may increase the MCR of glucocorticoids and decrease local glucocorticoid concentrations at these sites. By contrast, enhanced 11betaHSD1 in omental adipose tissue may increase local glucocorticoid receptor activation and promote obesity.
The Journal of Clinical Endocrinology and Metabolism | 2003
Robert S. Lindsay; Deborah J. Wake; Saraswathy Nair; Joy C. Bunt; Dawn Livingstone; Paska A. Permana; P. Antonio Tataranni; Brian R. Walker
The Journal of Clinical Endocrinology and Metabolism | 2003
Deborah J. Wake; Eva Rask; Dawn Livingstone; Stefan Söderberg; Tommy Olsson; Brian R. Walker
Endocrinology | 2005
Amanda J Drake; Dawn Livingstone; Ruth Andrew; Jonathan R. Seckl; Nicholas M. Morton; Brian R. Walker
Society for Endocrinology BES 2017 | 2017
Amber J. Abernethie; Giorgia Maltese; Dawn Livingstone; Annalisa Gastaldello; Ruth Morgan; Brian R. Walker; Patrick Hadoke; Ruth Andrew
Society for Endocrinology BES 2015 | 2015
Annalisa Gastaldello; Dawn Livingstone; Nicola Tsang; Brian R. Walker; Patrick Hadoke; Ruth Andrew
Society for Endocrinology BES 2015 | 2015
Tracy C S Mak; Dawn Livingstone; Brian R. Walker; Ruth Andrew
Society for Endocrinology BES 2013 | 2013
Dawn Livingstone; Georgina Rees; Benjamin Weldin; David P. Macfarlane; Brian R. Walker; Ruth Andrew
Archive | 2013
Ruth Andrew; Rita Upreti; Dawn Livingstone; Pascal Barat; Kate Hughes; David P. Macfarlane; Calum Gray; Fiona C. Minns; Ian Marshall; Laura Stewart; Brian R. Walker
Society for Endocrinology BES 2012 | 2012
Rollo Emma Di; Dawn Livingstone; Brian R. Walker; Ruth Andrew